NATURE . COM {}

Matching Content Categories {📚}

• Education
• Science
• Insurance

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,058 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$63,100 per month
Our calculations suggest that Nature.com earns between $42,042 and $115,617 monthly online from display advertisements.

Keywords {🔍}

retinal, ischemic, kus, injury, control, cell, layer, article, group, cells, rats, thickness, retina, pubmed, google, scholar, vcp, insult, fig, doi, rgcs, ganglion, ischemia, days, death, effects, outer, neuroprotective, images, nuclear, cas, rat, kustreated, research, stress, model, nature, significantly, bwave, protein, number, diseases, treatment, test, treated, groups, sections, rgc, chop, error,

Topics {✒️}

nature portfolio privacy policy nature genetics 36 nature advertising social media monosodium iodoacetate-induced osteoarthritis pressure-induced ischaemia-reperfusion insult index 0/ reprints author information authors cell death-inducing insults pct/jp2011/067320&pct/jp2011/073160 japan research foundation er stress-induced molecule author correspondence facial nerve research er stress-reducing activities integrated medical bio-imaging nampt-dependent nad+ salvage transgenic thy1-gfp rat proteasome-mediated protein degradation joint research project flat-mounted retinal imaging light-emitting diode stimulator ganglion cell complex fewer tunel-positive cells thy1-green fluorescent protein decreased b-wave amplitude investigator-initiated clinical trial fewer chop-positive rgcs ivt-kus121–treated group compared flat-mounted retinal images ischemia-reperfusion injured retina flat-mounted retinas treated ganglion cell layer profound anti-apoptotic effect retinal ischemia-reperfusion injury permissions 5 mg/kg body weight colorimetric-tdt enzyme assessed b-wave amplitudes vcp/p97 aaa-atpase neuronal cell death human subjects subjected anti-cleaved caspase-3 antibody induces cell death necrotic cell death gfp-positive rgc numbers japan national society

Schema {🗺️}

WebPage:
      mainEntity:
         headline:KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress
         description:Ischemic neural damages cause several devastating diseases, including brain stroke and ischemic retinopathies, and endoplasmic reticulum (ER) stress has been proposed to be the underlying mechanism of the neuronal cell death of these conditions. We previously synthesized Kyoto University substances (KUSs) as modulators of valosin-containing protein (VCP); KUSs inhibit VCP ATPase activity and protect cells from different cell death-inducing insults. Here, we examined the efficacy of KUS121 in a rat model of retinal ischemic injury. Systemic administration of KUS121 to rats with ischemic retinal injury significantly suppressed inner retinal thinning and death of retinal ganglion and amacrine cells, with a significant functional maintenance of visual functions, as judged by electroretinography. Furthermore, intravitreal injection of KUS121, which is the clinically preferred route of drug administration for retinal diseases, appeared to show an equal or better neuroprotective efficacy in the ischemic retina compared with systemic administration. Indeed, induction of the ER stress marker C/EBP homologous protein (CHOP) after the ischemic insult was significantly suppressed by KUS121 administration. Our study suggests VCP modulation by KUS as a promising novel therapeutic strategy for ischemic neuronal diseases.
         datePublished:2017-03-20T00:00:00Z
         dateModified:2017-03-20T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/srep44873
         keywords:
            Drug discovery
            Neurological disorders
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig5_HTML.jpg
         isPartOf:
            name:Scientific Reports
            issn:
               2045-2322
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Masayuki Hata
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hanako O. Ikeda
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Chinami Kikkawa
               affiliation:
                     name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
                     address:
                        name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sachiko Iwai
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuki Muraoka
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tomoko Hasegawa
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akira Kakizuka
               affiliation:
                     name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
                     address:
                        name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nagahisa Yoshimura
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress
      description:Ischemic neural damages cause several devastating diseases, including brain stroke and ischemic retinopathies, and endoplasmic reticulum (ER) stress has been proposed to be the underlying mechanism of the neuronal cell death of these conditions. We previously synthesized Kyoto University substances (KUSs) as modulators of valosin-containing protein (VCP); KUSs inhibit VCP ATPase activity and protect cells from different cell death-inducing insults. Here, we examined the efficacy of KUS121 in a rat model of retinal ischemic injury. Systemic administration of KUS121 to rats with ischemic retinal injury significantly suppressed inner retinal thinning and death of retinal ganglion and amacrine cells, with a significant functional maintenance of visual functions, as judged by electroretinography. Furthermore, intravitreal injection of KUS121, which is the clinically preferred route of drug administration for retinal diseases, appeared to show an equal or better neuroprotective efficacy in the ischemic retina compared with systemic administration. Indeed, induction of the ER stress marker C/EBP homologous protein (CHOP) after the ischemic insult was significantly suppressed by KUS121 administration. Our study suggests VCP modulation by KUS as a promising novel therapeutic strategy for ischemic neuronal diseases.
      datePublished:2017-03-20T00:00:00Z
      dateModified:2017-03-20T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/srep44873
      keywords:
         Drug discovery
         Neurological disorders
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig5_HTML.jpg
      isPartOf:
         name:Scientific Reports
         issn:
            2045-2322
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Masayuki Hata
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hanako O. Ikeda
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Chinami Kikkawa
            affiliation:
                  name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
                  address:
                     name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sachiko Iwai
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuki Muraoka
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tomoko Hasegawa
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akira Kakizuka
            affiliation:
                  name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
                  address:
                     name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nagahisa Yoshimura
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Scientific Reports
      issn:
         2045-2322
      volumeNumber:7
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
      name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
      address:
         name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
      address:
         name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Masayuki Hata
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Hanako O. Ikeda
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Chinami Kikkawa
      affiliation:
            name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
            address:
               name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
               type:PostalAddress
            type:Organization
      name:Sachiko Iwai
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Yuki Muraoka
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Tomoko Hasegawa
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Akira Kakizuka
      affiliation:
            name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
            address:
               name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Nagahisa Yoshimura
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
      name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan

Social Networks {👍}(2)

• https://www.facebook.com/scientificreports
• https://twitter.com/SciReports

External Links {🔗}(120)

• How much does https://doi.org/10.1161%2FCIR.0b013e31823ac046 gross monthly?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22179539 generate?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Heart%20disease%20and%20stroke%20statistics%E2%80%932012%20update%3A%20a%20report%20from%20the%20American%20Heart%20Association&journal=Circulation&doi=10.1161%2FCIR.0b013e31823ac046&volume=125&pages=e2-e220&publication_year=2012&author=Roger%2CVL make?
• What's the profit of https://doi.org/10.1016%2Fj.jemermed.2012.05.005?
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22818644
• How much money does http://scholar.google.com/scholar_lookup?&title=Tissue%20plasminogen%20activator%20and%20stroke%3A%20review%20of%20the%20literature%20for%20the%20clinician&journal=J%20Emerg%20Med&doi=10.1016%2Fj.jemermed.2012.05.005&volume=43&pages=1149-1154&publication_year=2012&author=DeMers%2CG&author=Meurer%2CWJ&author=Shih%2CR&author=Rosenbaum%2CS&author=Vilke%2CGM make?
• How much money does https://doi.org/10.1016%2Fj.preteyeres.2003.12.001 make?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Retinal%20ischemia%3A%20mechanisms%20of%20damage%20and%20potential%20therapeutic%20strategies&journal=Prog%20Retin%20Eye%20Res&doi=10.1016%2Fj.preteyeres.2003.12.001&volume=23&pages=91-147&publication_year=2004&author=Osborne%2CNN?
• https://doi.org/10.1167%2Fiovs.06-0510's financial summary
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17197555
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Retinal%20ischemia%20and%20reperfusion%20causes%20capillary%20degeneration%3A%20similarities%20to%20diabetes&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.06-0510&volume=48&pages=361-367&publication_year=2007&author=Zheng%2CL&author=Gong%2CB&author=Hatala%2CDA&author=Kern%2CTS?
• What's the financial intake of https://link.springer.com/doi/10.1007/BF00155046?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=817878 have monthly?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Tributary%20vein%20obstruction%3A%20pathogenesis%20and%20treatment%20of%20sequelae&journal=Doc%20Ophthalmol&doi=10.1007%2FBF00155046&volume=40&pages=339-360&publication_year=1976&author=Archer%2CDB
• What's the income of https://doi.org/10.1038%2Fsj.cdd.4401365?
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14752508 have?
• How much does http://scholar.google.com/scholar_lookup?&title=Ischemia-induced%20neuronal%20cell%20death%20is%20mediated%20by%20the%20endoplasmic%20reticulum%20stress%20pathway%20involving%20CHOP&journal=Cell%20Death%20Differ&doi=10.1038%2Fsj.cdd.4401365&volume=11&pages=403-415&publication_year=2004&author=Tajiri%2CS bring in each month?
• https://doi.org/10.1016%2Fj.neulet.2014.05.042 income
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24880098's gross income?
• How much money does http://scholar.google.com/scholar_lookup?&title=Down-regulation%20of%20GRP78%20enhances%20apoptosis%20via%20CHOP%20pathway%20in%20retinal%20ischemia-reperfusion%20injury&journal=Neurosci%20Lett&doi=10.1016%2Fj.neulet.2014.05.042&volume=575&pages=68-73&publication_year=2014&author=Li%2CH&author=Zhu%2CX&author=Fang%2CF&author=Jiang%2CD&author=Tang%2CL make?
• How much does https://doi.org/10.1016%2Fj.brainres.2009.10.025 make?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19853589
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Retinal%20ganglion%20cell%20death%20induced%20by%20endoplasmic%20reticulum%20stress%20in%20a%20chronic%20glaucoma%20model&journal=Brain%20Res&doi=10.1016%2Fj.brainres.2009.10.025&volume=1308&pages=158-166&publication_year=2010&author=Doh%2CSH&author=Kim%2CJH&author=Lee%2CKM&author=Park%2CHY&author=Park%2CCK?
• What's the revenue for https://doi.org/10.2147%2FOPTH.S3009?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19668425 income
• How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699777 bring in?
• How much does http://scholar.google.com/scholar_lookup?&title=Increased%20expression%20of%20IRE1alpha%20and%20stress-related%20signal%20transduction%20proteins%20in%20ischemia-reperfusion%20injured%20retina&journal=Clin%20Ophthalmol&doi=10.2147%2FOPTH.S3009&volume=2&pages=743-752&publication_year=2008&author=Hata%2CN&author=Oshitari%2CT&author=Yokoyama%2CA&author=Mitamura%2CY&author=Yamamoto%2CS generate monthly?
• What's the monthly income of https://doi.org/10.1038%2Fsj.cdd.4400955?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11859409?
• How much money does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20ter94%2C%20Drosophila%20VCP%2C%20as%20a%20modulator%20of%20polyglutamine-induced%20neurodegeneration&journal=Cell%20Death%20Differ&doi=10.1038%2Fsj.cdd.4400955&volume=9&pages=264-273&publication_year=2002&author=Higashiyama%2CH make?
• Income figures for https://doi.org/10.1038%2Fng1332
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15034582 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Inclusion%20body%20myopathy%20associated%20with%20Paget%20disease%20of%20bone%20and%20frontotemporal%20dementia%20is%20caused%20by%20mutant%20valosin-containing%20protein&journal=Nature%20genetics&doi=10.1038%2Fng1332&volume=36&pages=377-381&publication_year=2004&author=Watts%2CGD pull in monthly?
• Earnings of https://doi.org/10.1016%2Fj.neuron.2010.11.036
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21145000's total income per month
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032425 rake in every month?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Exome%20sequencing%20reveals%20VCP%20mutations%20as%20a%20cause%20of%20familial%20ALS&journal=Neuron&doi=10.1016%2Fj.neuron.2010.11.036&volume=68&pages=857-864&publication_year=2010&author=Johnson%2CJO?
• What's the financial gain of https://doi.org/10.1016%2Fj.tibs.2011.06.001?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21741246 earning monthly?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Cdc48%3A%20a%20power%20machine%20in%20protein%20degradation&journal=Trends%20Biochem%20Sci&doi=10.1016%2Fj.tibs.2011.06.001&volume=36&pages=515-523&publication_year=2011&author=Stolz%2CA&author=Hilt%2CW&author=Buchberger%2CA&author=Wolf%2CDH make?
• What's the financial outcome of https://doi.org/10.1038%2Fncb2407?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22298039 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Emerging%20functions%20of%20the%20VCP%2Fp97%20AAA-ATPase%20in%20the%20ubiquitin%20system&journal=Nat%20Cell%20Biol&doi=10.1038%2Fncb2407&volume=14&pages=117-123&publication_year=2012&author=Meyer%2CH&author=Bug%2CM&author=Bremer%2CS gross monthly?
• How much does https://doi.org/10.1016%2Fj.bbamcr.2011.09.002 earn?
• See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21945179 makes per month
• How much does http://scholar.google.com/scholar_lookup?&title=The%20Cdc48%20machine%20in%20endoplasmic%20reticulum%20associated%20protein%20degradation&journal=Biochim%20Biophys%20Acta&doi=10.1016%2Fj.bbamcr.2011.09.002&volume=1823&pages=117-124&publication_year=2012&author=Wolf%2CDH&author=Stolz%2CA pull in monthly?
• How much revenue does https://doi.org/10.1038%2Fsrep05970 bring in?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25096051?
• See how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122966 makes per month
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Novel%20VCP%20modulators%20mitigate%20major%20pathologies%20of%20rd10%2C%20a%20mouse%20model%20of%20retinitis%20pigmentosa&journal=Sci%20Rep&doi=10.1038%2Fsrep05970&volume=4&publication_year=2014&author=Ikeda%2CHO?
• Check the income stats for https://doi.org/10.1038%2Fsrep31184
• http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2016NatSR...631184H's total income per month
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27503804 making per month?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977562 pull in monthly?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Neuroprotective%20efficacies%20by%20KUS121%2C%20a%20VCP%20modulator%2C%20on%20animal%20models%20of%20retinal%20degeneration&journal=Sci%20Rep&doi=10.1038%2Fsrep31184&volume=6&publication_year=2016&author=Hasegawa%2CT
• How much does https://doi.org/10.1001%2Farchfacial.2010.71 generate monthly?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20855773
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=A%20new%20model%20for%20facial%20nerve%20research%3A%20the%20novel%20transgenic%20Thy1-GFP%20rat&journal=Arch%20Facial%20Plast%20Surg&doi=10.1001%2Farchfacial.2010.71&volume=12&pages=315-320&publication_year=2010&author=Magill%2CCK&author=Moore%2CAM&author=Borschel%2CGH&author=Mackinnon%2CSE?
• How much does https://doi.org/10.1016%2FS0014-4835%2805%2980173-3 pull in?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1483506
• How much profit is http://scholar.google.com/scholar_lookup?&title=Cell%20death%20in%20the%20rat%20retina%20after%20a%20pressure-induced%20ischaemia-reperfusion%20insult%3A%20an%20electron%20microscopic%20study.%20I.%20Ganglion%20cell%20layer%20and%20inner%20nuclear%20layer&journal=Exp%20Eye%20Res&doi=10.1016%2FS0014-4835%2805%2980173-3&volume=55&pages=605-613&publication_year=1992&author=Buchi%2CER making per month?
• What are the total earnings of https://doi.org/10.1167%2Fiovs.07-1211?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18689704 gross monthly?
• How much money does http://scholar.google.com/scholar_lookup?&title=Imaging%20mouse%20retinal%20ganglion%20cells%20and%20their%20loss%20in%20vivo%20by%20a%20fundus%20camera%20in%20the%20normal%20and%20ischemia-reperfusion%20model&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.07-1211&volume=49&pages=5546-5552&publication_year=2008&author=Murata%2CH make?
• What's the total monthly financial gain of https://doi.org/10.1167%2Fiovs.13-13372?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Loss%20of%20inner%20retinal%20neurons%20after%20retinal%20ischemia%20in%20rats&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.13-13372&volume=55&pages=2777-2787&publication_year=2014&author=Schmid%2CH&author=Renner%2CM&author=Dick%2CHB&author=Joachim%2CSC
• What's the revenue for https://doi.org/10.1016%2Fj.preteyeres.2007.09.003?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18042420 bring in?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Rodent%20electroretinography%3A%20methods%20for%20extraction%20and%20interpretation%20of%20rod%20and%20cone%20responses&journal=Prog%20Retin%20Eye%20Res&doi=10.1016%2Fj.preteyeres.2007.09.003&volume=27&pages=1-44&publication_year=2008&author=Weymouth%2CAE&author=Vingrys%2CAJ
• How much revenue does https://doi.org/10.1016%2F0014-4835%2891%2990215-Z generate?
• Get to know http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=1991elpa.book.....H's earnings
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1743256 produce monthly?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Quantitation%20of%20ischemic%20damage%20in%20the%20rat%20retina&journal=Exp%20Eye%20Res&doi=10.1016%2F0014-4835%2891%2990215-Z&volume=53&pages=573-582&publication_year=1991&author=Hughes%2CWF?
• How much revenue does https://doi.org/10.1167%2Fiovs.09-4086 bring in?
• http://scholar.google.com/scholar_lookup?&title=Retinal%20protection%20from%20acute%20glaucoma-induced%20ischemia-reperfusion%20injury%20through%20pharmacologic%20induction%20of%20heme%20oxygenase-1&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.09-4086&volume=51&pages=4798-4808&publication_year=2010&author=Sun%2CMH's total income per month
• Monthly income for https://doi.org/10.1016%2FS0306-3623%2897%2900359-5
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9510075?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=The%20b-wave%20of%20the%20electroretinogram%20as%20an%20index%20of%20retinal%20ischemia&journal=Gen%20Pharmacol&doi=10.1016%2FS0306-3623%2897%2900359-5&volume=30&pages=281-287&publication_year=1998&author=Block%2CF&author=Schwarz%2CM?
• Revenue of https://doi.org/10.1056%2FNEJMe1103334
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21526924?
• What's http://scholar.google.com/scholar_lookup?&title=Bevacizumab%20versus%20ranibizumab%20for%20AMD&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMe1103334&volume=364&pages=1966-1967&publication_year=2011&author=Rosenfeld%2CPJ's gross income?
• How much profit is https://doi.org/10.1056%2FNEJMoa1414264 making per month?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25692915's financial summary
• How much does http://scholar.google.com/scholar_lookup?&title=Aflibercept%2C%20bevacizumab%2C%20or%20ranibizumab%20for%20diabetic%20macular%20edema&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1414264&volume=372&pages=1193-1203&publication_year=2015&author=Wells%2CJA rake in every month?
• https://doi.org/10.1016%2FS0161-6420%2891%2932135-3 income
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20tolerance%20of%20intravitreal%20ganciclovir%20in%20cytomegalovirus%20retinitis%20in%20acquired%20immune%20deficiency%20syndrome&journal=Ophthalmology&doi=10.1016%2FS0161-6420%2891%2932135-3&volume=98&pages=1353-1345&publication_year=1991&author=Cochereau-Massin%2CI each month?
• What's the revenue for https://doi.org/10.1111%2Fj.1755-3768.2011.02247.x?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21914149 gross monthly?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Repeat%20intravitreal%20triamcinolone%20acetonide%20injections%20in%20uveitic%20macular%20oedema&journal=Acta%20Ophthalmol&doi=10.1111%2Fj.1755-3768.2011.02247.x&volume=90&pages=e323-325&publication_year=2012&author=Sallam%2CA
• Explore the financials of https://citation-needed.springer.com/v2/references/10.1038/srep44873?format=refman&flavour=references
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masayuki%20Hata
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masayuki%20Hata%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hanako%20O.%20Ikeda
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hanako%20O.%20Ikeda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
• What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chinami%20Kikkawa?
• What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chinami%20Kikkawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sachiko%20Iwai?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sachiko%20Iwai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
• How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuki%20Muraoka earning monthly?
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuki%20Muraoka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tomoko%20Hasegawa?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tomoko%20Hasegawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akira%20Kakizuka's financial summary
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akira%20Kakizuka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nagahisa%20Yoshimura
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nagahisa%20Yoshimura%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• How much does https://static-content.springer.com/esm/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_BFsrep44873_MOESM49_ESM.pdf rake in every month?
• What's the monthly money flow for http://creativecommons.org/licenses/by/4.0/?
• Learn about the earnings of https://s100.copyright.com/AppDispatchServlet?title=KUS121%2C%20a%20VCP%20modulator%2C%20attenuates%20ischemic%20retinal%20cell%20death%20via%20suppressing%20endoplasmic%20reticulum%20stress&author=Masayuki%20Hata%20et%20al&contentID=10.1038%2Fsrep44873©right=The%20Author%28s%29&publication=2045-2322&publicationDate=2017-03-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
• Get to know what's the income of https://crossmark.crossref.org/dialog/?doi=10.1038/srep44873
• Check the income stats for https://citation-needed.springer.com/v2/references/10.1038/srep44873?format=refman&flavour=citation
• What's the financial outcome of https://doi.org/10.1038/s41420-022-01007-3?
• Check the income stats for https://doi.org/10.1038/s41598-022-20497-w
• Financial intake of https://doi.org/10.1038/s41598-021-95173-6
• Monthly income for https://doi.org/10.1038/s41598-020-61160-6
• How profitable is https://doi.org/10.1038/s41598-020-77735-2?
• How much does https://www.protocols.io/ bring in each month?
• Discover the revenue of https://www.natureindex.com/
• How much does http://www.naturechina.com earn?
• How much revenue does https://www.natureasia.com/ja-jp bring in?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref